NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

55 hedge funds and large institutions have $10.1M invested in Navidea Biopharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 7 closing their positions.

Holders
55
Holders Change
–
Holders Change %
0%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
13
Closed
7
Calls
$8K
Puts
$75K
Net Calls
-$67K
Net Calls Change
+$39K

Top Buyers

1
SIM
1
Spark Investment Management
New York
$267K
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$113K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.86M
4
BIT
4
BlackRock Institutional Trust
California
$1.7M
5
HIIFS
5
Harel Insurance Investments & Financial Services
Israel
$717K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$521K
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$154K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$16K
4
Millennium Management
4
Millennium Management
New York
$529K
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
51
IFP Advisors
Florida
$1K – – –
Citigroup
52
Citigroup
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
SQA
54
Simon Quick Advisors
New Jersey
$1K +$1K +10 New
Citadel Advisors
55
Citadel Advisors
Florida
– -$63K -3,426 Closed
SI
56
Stephens Inc
Arkansas
– -$14K -750 Closed
FAG
57
Financial Advisory Group
Texas
– -$11K -625 Closed
Simplex Trading
58
Simplex Trading
Illinois
– -$2K -150 Closed
JPMorgan Chase & Co
59
JPMorgan Chase & Co
New York
– -$2K -136 Closed
1 2
3